Medical Innovation Exchange

Eli Lilly shut out of Alzheimer’s fast lane with FDA rejection for donanemab

https://www.fiercebiotech.com/biotech/eli-lilly-shut-out-alzheimers-fast-lane-complete-response-letter-donanemab

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!